Archive

Volume 24/2, December 2022, pp. 205-209 |  PDF Rosalind Turkie Introduction Pharmaceutical companies have the power and the responsibility to help governments realize the human right to health for all, yet there are egregious…

Volume 24/2, December 2022, pp. 191-204 |  PDF Katrina Perehudoff and Jennifer Sellin Abstract Facing the unmet need for new, affordable medicines for public health crises, how should states’ duty to ensure that everyone shares in the…

Volume 24/2, December 2022, pp. 159-175 |  PDF Jillian Kohler, Anna Wong, and Lauren Tailor Abstract Throughout the COVID-19 pandemic, international access to COVID-19 vaccines and other health technologies has remained highly asymmetric.…

Volume 24/2, December 2022, pp. 141-157 |  PDF Katrina Perehudoff, Heba Qazilbash, and Kai Figueras de Vries Abstract How and why is implicit and explicit human rights language used by World Trade Organization (WTO) negotiators in debates…

Volume 24/2, December 2022, pp. 125-140 |  PDF Lisa Forman, Basema Al-Alami, and Kaitlin Fajber Abstract Global disparities in access to COVID-19 vaccines have brought back into focus questions about whether the right to medicines has…

Volume 24/2, December 2022, pp. 121-124 |  PDF Lisa Forman, Carlos Correa, and Katrina Perehudoff Introduction Access to safe and effective COVID-19 vaccines is central to controlling the global COVID-19 pandemic. It is also an essential…